Rapid Dose Therapeutics (XCNQ:DOSE) Accounts Payable & Accrued Expense : C$3.16 Mil (As of Nov. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics Accounts Payable & Accrued Expense?

Rapid Dose Therapeutics's quarterly accounts payable & accrued expense increased from May. 2024 (C$2.55 Mil) to Aug. 2024 (C$2.87 Mil) and increased from Aug. 2024 (C$2.87 Mil) to Nov. 2024 (C$3.16 Mil).

Rapid Dose Therapeutics's annual accounts payable & accrued expense increased from Feb. 2022 (C$1.62 Mil) to Feb. 2023 (C$3.29 Mil) but then declined from Feb. 2023 (C$3.29 Mil) to Feb. 2024 (C$2.80 Mil).

Rapid Dose Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Rapid Dose Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Accounts Payable & Accrued Expense Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.68

1.96

1.62

3.29

2.80

Rapid Dose Therapeutics Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3.77	2.80	2.55	2.87	3.16

Rapid Dose Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

RDTCF:USA

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Executives

Mark Upsdell	Director
Brian Howlett	Director

Rapid Dose Therapeutics Headlines

No Headlines